untitled design

Coreper: Hopes for vaccines adapted to coronavirus variants by autumn

The European Medicines Agency (EMA) announced today that it hopes to have vaccines adapted to treat coronavirus variants, such as Omicron, which will be approved by September.

“Our priority is to ensure that customized vaccines are likely to be approved by September at the latest to be ready for new immunization campaigns in the EU in the autumn,” said Marco Cavaleri, head of biological threats to health and the EMA vaccine strategy.

“This will allow manufacturers to adapt their product lines accordingly.”

The mRNA vaccines developed by Pfizer-BioNTech and Moderna are the most advanced and clinical trials are ongoing.

It remains unclear whether the vaccines will target one or two variants in a single dose, Cavaleri added.

Source: Capital

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular